David Blivin
President & CEO @ Cottonwood Technology Fund
Santa Fe, United States
David Blivin is a Series A investor at Cottonwood Technology Fund in Santa Fe focused on Biotechnology and Manufacturing. Dave is co-founder and a managing director of Cottonwood Technology Fund. Cottonwood Technology Fund is focused on early/seed stage companies and brings with it an extensive network to additional capital and strategic customers/partners. Dave has experience working with the national labs and the research universities throughout thesouthwest at the leadership and research head levels. Prior to co-founding Cottonwood Technology Fund, Dave founded and served as Managing Director of Southeast Interactive, the first and largest information technology-focused fund based in the Southeast. While at Southeast Interactive (SEI), Dave was responsible for raising three funds totaling over $175 million. He was directly involved in fund raising and exit transaction events totaling in excess of $1 billion across the SEI portfolio and generated cash on cash returns on his directed investments of approximately 4X. Dave holds a MBA from the Fuqua School of Business at Duke University.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 61%
Last updated:
For AI agents: llms.txt
Industries David Blivin invests in
Stages David Blivin invests in
Countries David Blivin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 4 (14%)
- Manufacturing 4 (14%)
- Medical 3 (11%)
- Chemical 3 (11%)
- Health Care 3 (11%)
Stage
- Series A 8 (29%)
- Seed 4 (14%)
- Series B 3 (11%)
- Series C 2 (7%)
- Debt Financing 2 (7%)
Country
- United States 11 (39%)
- The Netherlands 2 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Green Theme Technologies
|
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. | $6M / Series C / Nov 06, 2024 | |
|
Green Theme Technologies
|
Green Theme Technologies is a developer of environmentally-friendly, dry textile finishing technology. It is a textile innovation company with the mission to create products that out-perform existing technologies while eliminating water usage and pollution. The company was founded in 2012 and is based in Rio Rancho, New Mexico. | $5.4M / Series B / Oct 07, 2022 | |
BioFlyte
|
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security.Our products are designed to autonomously sample ambient air, for example, in critical infrastructure, but can also accept liquid or powder samples manually. | $6.1M / Series A / Apr 19, 2022 | |
mPower Technology
|
mPower Technology is an innovative solar cell technology startup.They are an experienced team of technology innovators and industry veterans out to shape the future of solar power around the globe. | $10M / Series B / Feb 01, 2022 | |
Circular Genomics
|
Circular Genomics develops circular RNA (circRNA)-based diagnostic and biomarker tools for neurological and psychiatric disorders. The company uses brain-derived circRNAs, a class of stable non-coding RNA molecules enriched in the brain, to build blood-based assays that reflect disease biology in real time. Its first product, MindLight™, predictswhether a patient with major depressive disorder will respond to SSRI antidepressants. Circular Genomics is also creating additional assays designed for early detection and risk prediction of neurodegenerative diseases such as Alzheimer’s disease. The company applies its circRNA platform to help clinicians make more informed treatment decisions using molecular indicators of brain health. | $4.5M / Seed / Dec 14, 2021 | |
|
mPower Technology
|
mPower Technology is an innovative solar cell technology startup.They are an experienced team of technology innovators and industry veterans out to shape the future of solar power around the globe. | $1.9M / Series A / Mar 24, 2020 | |
Eurekite
|
Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. | $1.8M / Series A / Aug 01, 2018 | |
Flexiramics
|
Flexiramics combines ceramic properties such as heat resistance and chemical stability with the flexibility and lightweight characteristics typically associated with polymers. The company supports use cases including high-frequency electronics, thermal management, battery components, and advanced filtration media. It collaborates with partners toco-develop materials tailored to specific performance and manufacturing requirements. Its offerings also extend to advisory and technical support for integrating these materials into commercial products. | $1.9M / Series A / Aug 01, 2018 | |
|
Eurekite
|
Eurekite is a scientific and creative company with expertise in formulation chemistry, production technology, and composite development.The company was incorporated in May 2015 as a spin off from the university to further develop and commercialize the technology. The disruptive flexible ceramic technology attracted Cottonwood Technology Fund, atop performing early stage VC firm from U.S.Eurekite’s birthplace is the University of Twente, which is located in Enschede, The Netherlands. The Flexiramics® technology was developed at the Inorganic Materials Science Group (IMS) of MESA + Institute for Nanotechnology, under the supervision of Prof. Andre ten Elshof. | $1.3M / Seed / Sep 11, 2015 | |
Masterson Industries
|
Masterson Industries is a new venture focused on the development and production of specialty materials. We’ve built a significant Intellectual Property portfolio and recently moved into a new production facility. Our products enable new capabilities for a broad range of industries that include defense, medical devices, electronics, andtelecommunications. Most recently we’ve added sales and marketing expertise in each of the targeted industries. Transition from initial concept to a complete team poised for commercial expansion is complete. Preparation for the commercialization demonstration is underway. | $550K / Series A / Feb 25, 2015 | |
| See all 28 investments → | |||
Co-Investors
Cottonwood Technology Fund is a venture capital firm that focuses on high-tech / deeptech investments. It focuses on investing in patent-based high-tech and hardware startups Sectors: robotics, photonics, optics, nanotech, sensor tech, telecom, automotive, cleantech, green energy, Medtech, chemicals, and advanced materials.The company wasfounded in 2010 and headquartered in New Mexico, United States.
Cottonwood Technology Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alain le Loux
General Partner
|
|||
|
David Blivin
President & CEO
|
|||
Alan Abbott
Special Limited Partner
|
|||
Charles Call
Special Limited Partner
|
|||
Matthew Ongaro
Junior Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does David Blivin invest in?
David Blivin invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A and Seed stage. Most of the 28 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact David Blivin?
Public channels for David Blivin include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did David Blivin last invest?
The most recent investment recorded for David Blivin closed in Nov 2024. Shizune tracks 28 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
